BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Stock Fundamental Analysis
NYSE:BKDT - New York Stock Exchange, Inc. - US1124633025 - Currency: USD
BKDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. BKDT has a bad profitability rating. Also its financial health evaluation is rather negative. BKDT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BKDT had negative earnings in the past year.
BKDT had a positive operating cash flow in the past year.
In the past 5 years BKDT reported 4 times negative net income.
BKDT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BKDT has a Return On Assets (-3.19%) which is comparable to the rest of the industry.
The Return On Equity of BKDT (-95.04%) is worse than 76.36% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.76%, BKDT is in line with its industry, outperforming 42.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.19% | ||
| ROE | -95.04% | ||
| ROIC | 0.76% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKDT has a Operating Margin (1.76%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BKDT has grown nicely.
Looking at the Gross Margin, with a value of 25.57%, BKDT is in line with its industry, outperforming 50.91% of the companies in the same industry.
BKDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 25.57% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKDT is destroying value.
BKDT has more shares outstanding than it did 1 year ago.
BKDT has more shares outstanding than it did 5 years ago.
BKDT has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.14, we must say that BKDT is in the distress zone and has some risk of bankruptcy.
BKDT has a Altman-Z score of 1.14. This is in the lower half of the industry: BKDT underperforms 63.64% of its industry peers.
A Debt/Equity ratio of 20.19 is on the high side and indicates that BKDT has dependencies on debt financing.
The Debt to Equity ratio of BKDT (20.19) is worse than 84.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 20.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.14 |
ROIC/WACC0.09
WACC8.64%
2.3 Liquidity
A Current Ratio of 0.88 indicates that BKDT may have some problems paying its short term obligations.
BKDT has a worse Current ratio (0.88) than 78.18% of its industry peers.
A Quick Ratio of 0.88 indicates that BKDT may have some problems paying its short term obligations.
BKDT has a worse Quick ratio (0.88) than 70.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
BKDT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.95%.
BKDT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.63%.
The Revenue has been decreasing by -5.08% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
3.2 Future
BKDT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.13% yearly.
BKDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.10% yearly.
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKDT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKDT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKDT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 46.27 |
4.3 Compensation for Growth
BKDT's earnings are expected to grow with 18.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
5. Dividend
5.1 Amount
BKDT has a Yearly Dividend Yield of 4.51%, which is a nice return.
Compared to an average industry Dividend Yield of 2.51, BKDT pays a better dividend. On top of this BKDT pays more dividend than 97.27% of the companies listed in the same industry.
BKDT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.51% |
5.2 History
BKDT has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
BROOKDALE SENIOR LIVING - BKD 7 11/15/25
NYSE:BKDT (3/27/2025, 8:04:01 PM)
77.6
-2.09 (-2.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.89%
Inst Owner ChangeN/A
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap15.53B
Analysts73.33
Price Target105.12 (35.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.51% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.06%
Min EPS beat(2)-74.45%
Max EPS beat(2)-25.67%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-74.45%
Max EPS beat(4)26.45%
EPS beat(8)3
Avg EPS beat(8)-5.89%
EPS beat(12)4
Avg EPS beat(12)-2.98%
EPS beat(16)7
Avg EPS beat(16)16.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.88%
Revenue beat(12)0
Avg Revenue beat(12)-0.72%
Revenue beat(16)0
Avg Revenue beat(16)-1.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)10.25%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)8.42%
EPS NY rev (3m)8.42%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.97 | ||
| P/FCF | N/A | ||
| P/OCF | 93.48 | ||
| P/B | 73.11 | ||
| P/tB | 83.9 | ||
| EV/EBITDA | 46.27 |
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)0.83
OCFY1.07%
SpS15.61
BVpS1.06
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.19% | ||
| ROE | -95.04% | ||
| ROCE | 0.96% | ||
| ROIC | 0.76% | ||
| ROICexc | 0.8% | ||
| ROICexgc | 0.81% | ||
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 25.57% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 20.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.15 | ||
| Cap/Depr | 84.26% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 39.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1.14 |
F-Score6
WACC8.64%
ROIC/WACC0.09
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
EBIT growth 1Y142.36%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year517.25%
EBIT Next 3Y97.55%
EBIT Next 5YN/A
FCF growth 1Y-102.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2%
OCF growth 3YN/A
OCF growth 5Y-5.14%